ID

14826

Descrição

PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT02448576

Link

https://clinicaltrials.gov/show/NCT02448576

Palavras-chave

Versões (1)
  1. 30/04/2016 30/04/2016 -
Transferido a

30 de abril de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Breast Cancer NCT02448576

Inglês

Eligibility Breast Cancer NCT02448576

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. signed informed consent;
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
2. age of 18 to 65 years;
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
3. documented advanced breast cancer, clinical and pathological confirmed;
Descrição

Advanced breast cancer

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3495917
4. immunohistochemical examination:er<1%+, progestin receptor (pr)<1%+, her-2 -/+ or her-2(++)with negative result of fish;
Descrição

Immunohistochemistry | Status of estrogen receptors of neoplasm | Status of progesterone receptors of neoplasm | erbB-2 Receptor | Fluorescent in Situ Hybridization

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021044
UMLS CUI [2]
C2919271
UMLS CUI [3]
C2919590
UMLS CUI [4]
C0069515
UMLS CUI [5]
C0162789
5. a response after four to eight cycles of first line chemotherapy;
Descrição

Disease Response First line treatment Chemotherapy Regimen

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1704632
UMLS CUI [1,2]
C1708063
UMLS CUI [1,3]
C0392920
6. life expectancy longer than six months evaluated by investigator;
Descrição

Life Expectancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023671
7. a performance status of 0 to 2, according to the criteria of the world health organization (with a higher score indicating a poorer performance status)
Descrição

WHO performance status finding | Score

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1298651
UMLS CUI [2]
C0449820
8. less than grade 1( common terminology criteria grade version 4.0) of treatment-related toxicities;
Descrição

Toxic effect Finding related to participation with treatment Common Terminology Criteria for Adverse Events

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C1301588
UMLS CUI [1,3]
C1516728
9. adequate baseline organ function.
Descrição

body system or organ function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0678852
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. history of another malignancy.
Descrição

Malignant Neoplasms

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0006826
2. pregnancy or gestation
Descrição

Pregnancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
3. definite diagnosed of central nervous system (cns)or leptomeningeal metastases
Descrição

CNS metastases | Metastatic Malignant Neoplasm to the Leptomeninges

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0686377
UMLS CUI [2]
C1704231
4. serious cardiac illness or medical condition
Descrição

Heart Diseases

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0018799
5. known history of related central nervous system or leptomeningeal disease
Descrição

CNS disorder | Leptomeningeal disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0007682
UMLS CUI [2]
C3160796
6. cognition impairment or suffering from mental illness
Descrição

Impaired cognition | Mental disorders

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0338656
UMLS CUI [2]
C0004936
7. demand a long-term oral administration of psychotropic drugs
Descrição

Psychotropic Drugs Oral Administration Long-term

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0033978
UMLS CUI [1,2]
C0001563
UMLS CUI [1,3]
C0443252
8. have a concurrent disease or condition that may interfere with study participation, or any serious medical disorder that would interfere with the subject's safety (for example, active or uncontrolled infection, currently active/requiring anti-viral therapy hepatic or biliary disease)
Descrição

Comorbidity Study Subject Participation Status Limited | Disease Affecting patient safety | Disease | Antiviral Therapy | Liver diseases | Gall Bladder Diseases

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C0439801
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C1113679
UMLS CUI [3]
C0012634
UMLS CUI [4]
C0280274
UMLS CUI [5]
C0023895
UMLS CUI [6]
C0016977
Voltar ao início da página

Similar models

Eligibility Breast Cancer NCT02448576

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
1. signed informed consent;
boolean
C0021430 (UMLS CUI [1])
Age
Item
2. age of 18 to 65 years;
boolean
C0001779 (UMLS CUI [1])
Advanced breast cancer
Item
3. documented advanced breast cancer, clinical and pathological confirmed;
boolean
C3495917 (UMLS CUI [1])
Immunohistochemistry | Status of estrogen receptors of neoplasm | Status of progesterone receptors of neoplasm | erbB-2 Receptor | Fluorescent in Situ Hybridization
Item
4. immunohistochemical examination:er<1%+, progestin receptor (pr)<1%+, her-2 -/+ or her-2(++)with negative result of fish;
boolean
C0021044 (UMLS CUI [1])
C2919271 (UMLS CUI [2])
C2919590 (UMLS CUI [3])
C0069515 (UMLS CUI [4])
C0162789 (UMLS CUI [5])
Disease Response First line treatment Chemotherapy Regimen
Item
5. a response after four to eight cycles of first line chemotherapy;
boolean
C1704632 (UMLS CUI [1,1])
C1708063 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
Life Expectancy
Item
6. life expectancy longer than six months evaluated by investigator;
boolean
C0023671 (UMLS CUI [1])
WHO performance status finding | Score
Item
7. a performance status of 0 to 2, according to the criteria of the world health organization (with a higher score indicating a poorer performance status)
boolean
C1298651 (UMLS CUI [1])
C0449820 (UMLS CUI [2])
Toxic effect Finding related to participation with treatment Common Terminology Criteria for Adverse Events
Item
8. less than grade 1( common terminology criteria grade version 4.0) of treatment-related toxicities;
boolean
C0600688 (UMLS CUI [1,1])
C1301588 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
body system or organ function
Item
9. adequate baseline organ function.
boolean
C0678852 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms
Item
1. history of another malignancy.
boolean
C0006826 (UMLS CUI [1])
Pregnancy
Item
2. pregnancy or gestation
boolean
C0032961 (UMLS CUI [1])
CNS metastases | Metastatic Malignant Neoplasm to the Leptomeninges
Item
3. definite diagnosed of central nervous system (cns)or leptomeningeal metastases
boolean
C0686377 (UMLS CUI [1])
C1704231 (UMLS CUI [2])
Heart Diseases
Item
4. serious cardiac illness or medical condition
boolean
C0018799 (UMLS CUI [1])
CNS disorder | Leptomeningeal disease
Item
5. known history of related central nervous system or leptomeningeal disease
boolean
C0007682 (UMLS CUI [1])
C3160796 (UMLS CUI [2])
Impaired cognition | Mental disorders
Item
6. cognition impairment or suffering from mental illness
boolean
C0338656 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
Psychotropic Drugs Oral Administration Long-term
Item
7. demand a long-term oral administration of psychotropic drugs
boolean
C0033978 (UMLS CUI [1,1])
C0001563 (UMLS CUI [1,2])
C0443252 (UMLS CUI [1,3])
Comorbidity Study Subject Participation Status Limited | Disease Affecting patient safety | Disease | Antiviral Therapy | Liver diseases | Gall Bladder Diseases
Item
8. have a concurrent disease or condition that may interfere with study participation, or any serious medical disorder that would interfere with the subject's safety (for example, active or uncontrolled infection, currently active/requiring anti-viral therapy hepatic or biliary disease)
boolean
C0009488 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C1113679 (UMLS CUI [2,3])
C0012634 (UMLS CUI [3])
C0280274 (UMLS CUI [4])
C0023895 (UMLS CUI [5])
C0016977 (UMLS CUI [6])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial